Free Trial

Bank Julius Baer & Co. Ltd Zurich Lowers Position in Danaher Corporation (NYSE:DHR)

Danaher logo with Medical background

Bank Julius Baer & Co. Ltd Zurich decreased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 11.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,193,723 shares of the conglomerate's stock after selling 147,134 shares during the period. Danaher makes up 0.9% of Bank Julius Baer & Co. Ltd Zurich's holdings, making the stock its 28th biggest position. Bank Julius Baer & Co. Ltd Zurich owned 0.17% of Danaher worth $269,181,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in DHR. GHP Investment Advisors Inc. increased its position in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the period. Heck Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter worth $27,000. Sierra Ocean LLC increased its position in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher in the first quarter worth $31,000. Finally, Hurley Capital LLC bought a new position in shares of Danaher in the fourth quarter worth $34,000. Institutional investors own 79.05% of the company's stock.

Insiders Place Their Bets

In related news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president owned 15,179 shares of the company's stock, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the sale, the chairman directly owned 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Leerink Partners lifted their price target on Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a research note on Wednesday, April 23rd. Bank of America cut their price objective on Danaher from $265.00 to $230.00 in a research note on Monday, April 14th. Wells Fargo & Company cut their price objective on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research note on Wednesday. Finally, Argus cut their price objective on Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $247.61.

View Our Latest Stock Report on Danaher

Danaher Stock Up 2.7%

Danaher stock traded up $5.32 during trading on Thursday, hitting $203.21. 7,352,567 shares of the company were exchanged, compared to its average volume of 4,264,173. The business's 50 day moving average is $195.94 and its 200 day moving average is $204.39. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $281.70. The company has a market capitalization of $145.43 billion, a P/E ratio of 43.24, a PEG ratio of 2.65 and a beta of 0.77. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.80% and a net margin of 14.21%. The business's revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.72 EPS. Analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.63%. Danaher's dividend payout ratio is presently 24.85%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines